"As we prepare for the establishment of the Group, we are cognisant of the inherent risks of such a broad reaching reform agenda and the need to balance this with the need for reform to speed up patient access to new medicines," said chief executive Liz de Somer.
Medicines Australia strikes cautious tone on HTA review implementation group
October 2, 2024 Latest NewsBioPharmaNews of the DayLatest Video
New Stories
-
Pharmac announces expanded access to three cancer medicines
October 11, 2024 - - Latest News -
Novartis-led partnership says heart health shouldn't be dependent on where you live
October 11, 2024 - - Latest News -
Bondi Junction response must include increased funding and support for severe mental illness
October 11, 2024 - - Latest News -
New report unveils hidden cost of Alzheimer’s disease, with cases to double by 2050
October 10, 2024 - - Latest News -
Amplia Therapeutics CEO shares Prime Minister's Prize for Innovation
October 10, 2024 - - Latest News -
Healthy Bones Australia calls for greater Government commitment to bone health
October 9, 2024 - - Latest News -
TGA approves new indication for Telix’s Illuccix to include patient selection for PSMA-targeted therapy
October 9, 2024 - - Australian Biotech